| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.083 | 0.1 |